🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Lee's Pharmaceutical clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Lee's Pharmaceutical as lead sponsor. Synced 26 Sep 2026
5Current trials
5Recruiting now
4Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Lee's Pharmaceutical is the lead sponsor of 5 current clinical trials in our China register. 5 are recruiting patients now. The most common phase is Phase 1. The drugs named most often in its trials are Bevacizumab, Cisplatin/carboplatin and Nitric Oxide. The most-studied condition is Cancer.

ClinicalTrials.gov trials by status

  • Recruiting5100%

Trials by phase

  • Phase 1240%
  • Phase 3240%
  • Observational120%
01

Clinical trials sponsored by Lee's Pharmaceutical

5 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors
NCT06953453 · ClinicalTrials.gov ↗ · Cancer
Phase 1 Recruiting 2025-09 China
Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment
NCT06374485 · ClinicalTrials.gov ↗ · Advanced Hepatocellular Carcinoma
Phase 1 Recruiting 2024-05 China
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
NCT06459687 · ClinicalTrials.gov ↗ · Cervical Cancer
Phase 3 Recruiting 2024-11 China
Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)
NCT06160492 · ClinicalTrials.gov ↗ · 5-aminolevulinic Acid, Fluorescence-guided Resection
Phase 3 Recruiting 2025-04 China
Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension
NCT07099144 · ClinicalTrials.gov ↗ · Pulmonary Hypertension, Hypoxic Respiratory Failure
Observational Recruiting 2024-12 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Lee's Pharmaceutical trials

4 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Lee's Pharmaceutical trials

7 conditions
Cancer1Advanced Hepatocellular Carcinoma1Cervical Cancer15-aminolevulinic Acid1Fluorescence-guided Resection1Pulmonary Hypertension1Hypoxic Respiratory Failure1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China55

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Cancer

SponsorTrials
GRAIL4
Peking University Cancer Hospital & Institute4
Our Lady's Hospice and Care Services3
Conjupro Biotherapeutics3
University of Dublin, Trinity College2
Replimune2
Tempus AI2
Elephas2
First Hospital of China Medical University2
Qinghai Red Cross Hospital2

Sponsors with the most current trials registered for this condition.

06

Questions about Lee's Pharmaceutical trials

How many clinical trials does Lee's Pharmaceutical sponsor?

Lee's Pharmaceutical is the lead sponsor of 5 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Lee's Pharmaceutical trials recruiting?

Yes. 5 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Lee's Pharmaceutical testing?

Its current trials name 4 drugs and biologicals as interventions. The most frequent are Bevacizumab (1), Cisplatin/carboplatin (1), Nitric Oxide (1) and Paclitaxel (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.